Has Tyler Enos, MD received payments from drug or device companies?

Yes. Drug and device makers reported $483 in general payments to Tyler Enos, MD across 16 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tyler Enos, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tyler Enos, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tyler Enos, MD

Dermatology · Amarillo, TXNPI 1467988352

Payments from drug & device makers

$483in general payments, 2019–2025

Across 16 payments — averaging $30.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$383
AbbVie$100

What the payments were for

Food & beverage$483100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	15	$383
AbbVie	1	$100

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Skyrizi$100

How this compares

$483 in reported general payments places this provider in the 15th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas →

Medicare billing

Part B allowed, 2024

$311,841

Medicare patients

629

Services billed

5,206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	18	$77,684
Dupixent SyringeDupilumab	12	$44,087
Clobetasol Propionate	156	$6,540
Metronidazole	43	$2,766
Triamcinolone Acetonide	165	$2,479
Fluorouracil	36	$2,142
Tacrolimus	22	$1,917
Ketoconazole	141	$1,778
Doxycycline Monohydrate	70	$1,398
ValacyclovirValacyclovir Hcl	37	$1,178
Fluocinonide	21	$911
Minoxidil	85	$601
Gabapentin	56	$595
Hydroxychloroquine Sulfate	11	$492
MethotrexateMethotrexate Sodium	22	$336

Paid to pharmacies, not to this prescriber.

Other dermatology in Amarillo

Stephen TyringWebster$14.1M
Edward LainAustin$12M
Mark LeeSan Antonio$10.9M
John BrowningSan Antonio$10.7M
Craig TellerBellaire$7.7M
Patricia LeeWebster$7.2M
Jennifer CatherDallas$4.9M
Michael MigdenHouston$3.7M
Martin MenterDallas$3.7M
Janet DuboisAustin$3.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →